Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 6101 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 36 |
| 6102 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6103 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 68 |
| 6104 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 6105 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 60 |
| 6106 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 37 |
| 6107 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 6108 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 6109 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 65 |
| 6110 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 53 |
| 6111 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 59 |
| 6112 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 65 |
| 6113 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 41 |
| 6114 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 50 |
| 6115 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 68 |
| 6116 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 54 |
| 6117 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 24 |
| 6118 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 44 |
| 6119 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 55 |
| 6120 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 30 |
| 6121 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 50 |
| 6122 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 6123 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 6124 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 6125 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 19 |
| 6126 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 6127 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 29 |
| 6128 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 39 |
| 6129 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 48 |
| 6130 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 69 |
| 6131 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 38 |
| 6132 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 66 |
| 6133 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 50 |
| 6134 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 74 |
| 6135 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 18 |
| 6136 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 54 |
| 6137 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 6138 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 6139 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 54 |
| 6140 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 41 |
| 6141 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 53 |
| 6142 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 6143 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 71 |
| 6144 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 6145 | Apheresis | Allogeneic | Acute Myeloid Leukemia M2/M4 | Hematology | 2016 | Standard Therapy | Poland | 59 |
| 6146 | Apheresis | Allogeneic | Adrenoleukodystrophy | Metabolic | 2016 | Standard Therapy | Poland | 1 |
| 6147 | Apheresis | Autologous | Amyloid Light-Chain Amyloidosis | Hematology | 2016 | Standard Therapy | Germany | 45 |
| 6148 | Apheresis | Autologous | Amyloidosis | Hematology | 2016 | Standard Therapy | Germany | 71 |
| 6149 | Apheresis | Autologous | Anaplastic Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 6150 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 23 |
| 6151 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 44 |
| 6152 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 6153 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 6154 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 42 |
| 6155 | Apheresis | Autologous | Burkitt Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 40 |
| 6156 | Apheresis | Allogeneic | C-Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 60 |
| 6157 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 52 |
| 6158 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 6159 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6160 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6161 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6162 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2016 | Standard Therapy | Poland | 40 |
| 6163 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 53 |
| 6164 | Apheresis | Allogeneic | Composite Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 6165 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 39 |
| 6166 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 51 |
| 6167 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 64 |
| 6168 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma – Relapse | Hematology | 2016 | Standard Therapy | Germany | 69 |
| 6169 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2016 | Standard Therapy | Poland | 7 |
| 6170 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 38 |
| 6171 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6172 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6173 | Apheresis | Allogeneic | High-Risk Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 5 |
| 6174 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 31 |
| 6175 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6176 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 6177 | Apheresis | Autologous | Hodgkin Lymphoma-Relapse | Hematology | 2016 | Standard Therapy | Germany | 44 |
| 6178 | Apheresis | Allogeneic | Leukemia | Hematology | 2016 | Standard Therapy | Poland | 53 |
| 6179 | Apheresis | Allogeneic | Lymphoblastic Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 33 |
| 6180 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 56 |
| 6181 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6182 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 53 |
| 6183 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 60 |
| 6184 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2016 | Standard Therapy | Germany | 32 |
| 6185 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 59 |
| 6186 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 59 |
| 6187 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 44 |
| 6188 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 6189 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 70 |
| 6190 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 67 |
| 6191 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 6192 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6193 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 6194 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 73 |
| 6195 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 65 |
| 6196 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 6197 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 67 |
| 6198 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 59 |
| 6199 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 66 |
| 6200 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |